An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: Revise the reimbursement methodology for obstetrical services. To improve access to obstetrical services. To Increase reimbursement rates for vaginal deliveries and related care.
Summary: This SPA moves optometry services from optional coverage to a mandatory physician service, in order to allow Optometrists the ability to participate in Maryland's Medicaid Electronic HealthRecord (EHR) Incentive Program.
Summary: Proposes to delete a reference to therapeutically certified optometrists, clarify coverage criteria, increase the frequency of new frames for children through 7 years of age, and allow coverage of photo chromatic lenses and press on prisms effective November 1, 2012.
Summary: Excludes from coverage benzodiazepines for all conditions and barbiturates for the treatment of epilepsy, cancer and chronic mental health disorders for full benefit duel eligible as Medicare Part D will provide this coverage.